796 Results
La Salud Mental: Social Media Toolkit
La Salud Mental is our Spanish-language resource website offering evidence-based information on mental health and substance use disorders for Latino communities in the United States. The platform offers culturally relevant information about common mental health issues, treatments, and how to seek support. As part of our commitment to promoting mental health awareness in historically underserved populations, we encourage engagement through the hashtag #MenteSanaGenteSana, which emphasizes the imp
APA Releases Official Positions on Issues Affecting Mental Health in America
The American Psychiatric Association (APA) recently released a number of official position statements on a series of major issues affecting mental health for millions of Americans across the country. The statements, approved by APA’s Board of Trustees this month, represent official APA policy on issues of critical importance to mental health in America, including the need for continued research into the use of psychedelics to treat psychiatric disorders, the role of psychiatry in care of patient
American Psychiatric Association Joins “Sound the Alarm for Kids” to Address the Mental Health Emergency in Children and Teens
Learn more about American Psychiatric Association Joins “Sound the Alarm for Kids” to Address the Mental Health Emergency in Children and Teens at psychiatry.org
APA’s Goldwater Rule Remains a Guiding Principle for Physician Members
APA released the following statement regarding The Goldwater Rule.
Explore Sessions on Clinical Updates at the 2023 APA Annual Meeting
Check out some featured sessions in the Clinical Updates track at this year's Annual Meeting.
Choice and Control over Mental Health Services Can Lead to Better Outcomes
When people have some choice and control over their mental health care, they have better outcomes. That is the conclusion of a couple of recent studies looking at different aspects of choice in treatment and care.
APA and PaPS Joint Statement in Support of Dr. Rachel Levine’s Appointment as Assistant Secretary of Health
The American Psychiatric Association (APA) and the Pennsylvania Psychiatric Society (PaPS) today offered their formal support to the nomination of Rachel Levine, M.D., as President Biden’s Assistant Secretary of Health in the U.S. Department of Health and Human Services (HHS). Dr. Levine received APA’s 2018 Javits Award for Public Service, which is the highest honor the organization gives a public servant. She was selected for the award for her leadership in Pennsylvania in fighting the opioid e
Summer Premier of the APA Looking Beyond Maternal Mental Health Series
This mini-series focused on maternal mental health and provided a unique learning opportunity for psychiatrists, frontline maternal health providers, and maternal mental health clinicians to help address some of the gaps in information and training.
APA Applauds Congress for Taking Action to Strengthen Mental Health Parity; Including Key Mental Health Programs in Year-End Funding Package
The American Psychiatric Association (APA) today lauded Congress for passing the Strengthening Behavioral Health Parity Act (H.R. 7539) and including several key mental health and substance use-related programs in its combined $1.4 trillion year-end appropriations and COVID-relief funding package.
Suicide Prevention is a Community Effort
September is National Suicide Prevention Awareness Month, and all month long you’ll see the American Psychiatric Association (APA) and our allied groups sharing their knowledge and resources to foster education and confront the stigma around this topic.
APA Collaborates with YouTube to Develop Fact-based Mental Health Content; Receives “Accredited Health Educator” Label
Over the better part of a decade, health-related searches on social media platforms have increased exponentially. YouTube has more than 2 billion monthly logged-in users and every day, people watch over a billion hours of video and generate billions of views. To connect Americans with evidence-based information about mental health, the American Psychiatric Association has recently ramped up its efforts on this important platform.
FDA Approves Novel Depression Treatment
Last month, esketamine nasal spray became the first treatment for depression with a new mechanism of action approved by the Food and Drug Administration (FDA) since Prozac (fluoxetine hydrochloride) was approved in the late 1980s. Esketamine (sold as Spravato) has the potential to be extremely useful for people who have not responded to other treatments. Used in combination with an oral anti-depressant, it can take effect much faster than many common antidepressant medications. However, it comes